[go: up one dir, main page]

MX171542B - Composiciones farmaceuticas que contienen deoxirribonucleosidos para cicatrizacion de heridas - Google Patents

Composiciones farmaceuticas que contienen deoxirribonucleosidos para cicatrizacion de heridas

Info

Publication number
MX171542B
MX171542B MX015806A MX1580689A MX171542B MX 171542 B MX171542 B MX 171542B MX 015806 A MX015806 A MX 015806A MX 1580689 A MX1580689 A MX 1580689A MX 171542 B MX171542 B MX 171542B
Authority
MX
Mexico
Prior art keywords
pharmaceutical compositions
compositions containing
wound healing
containing deoxyribonucleosides
deoxyribonucleosides
Prior art date
Application number
MX015806A
Other languages
English (en)
Inventor
Reid Von Borstel
Michael Kevin Bamat
Original Assignee
Pro Neuron Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pro Neuron Inc filed Critical Pro Neuron Inc
Publication of MX171542B publication Critical patent/MX171542B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a una composición de materia que consiste de (a) de 10 a 90 por ciento molar de 2'-deoxicitidina y (b) de 90 a 10 por ciento molar de 2'-deoxiguanosina, o las sales farmaceuticamente aceptables de las mismas.
MX015806A 1988-04-25 1989-04-25 Composiciones farmaceuticas que contienen deoxirribonucleosidos para cicatrizacion de heridas MX171542B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US18603188A 1988-04-25 1988-04-25

Publications (1)

Publication Number Publication Date
MX171542B true MX171542B (es) 1993-11-04

Family

ID=22683377

Family Applications (1)

Application Number Title Priority Date Filing Date
MX015806A MX171542B (es) 1988-04-25 1989-04-25 Composiciones farmaceuticas que contienen deoxirribonucleosidos para cicatrizacion de heridas

Country Status (13)

Country Link
EP (1) EP0420862B1 (es)
JP (1) JPH0635389B2 (es)
AU (1) AU621368B2 (es)
CA (1) CA1336264C (es)
DE (1) DE68910973T2 (es)
DK (1) DK176007B1 (es)
FI (1) FI905236A0 (es)
HK (1) HK1005703A1 (es)
IN (1) IN169469B (es)
MX (1) MX171542B (es)
RU (1) RU2115410C1 (es)
WO (1) WO1989010129A1 (es)
ZA (1) ZA892928B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2444071C (en) * 1991-02-08 2008-10-07 Wellstat Therapeutics Corporation Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis
AU7319994A (en) * 1993-06-30 1995-01-24 Board Of Regents, The University Of Texas System Nucleotide preparation and uses thereof in wound healing
US6342484B1 (en) 1993-06-30 2002-01-29 Board Of Regents, The University Of Texas Systems Method and compositions for promotion of wound treatment
CN1113647A (zh) * 1993-08-25 1995-12-20 株式会社大制药工场 心脏恢复剂
US5852000A (en) * 1993-08-25 1998-12-22 Otsuka Pharmaceutical Factory, Inc. Cardiac rehabilitation agent
US20020006913A1 (en) * 1997-11-04 2002-01-17 Von Borstel Reid W. Antimutagenic compositions for treatment and prevention of photodamage to skin
US20040037828A1 (en) 2002-07-09 2004-02-26 Bar-Ilan University Methods and pharmaceutical compositions for healing wounds
WO2005013885A2 (en) 2003-08-07 2005-02-17 Healor Ltd. Pharmaceutical compositions and methods for accelerating wound healing
AU2006286152B2 (en) 2005-08-29 2012-05-31 Healor Ltd. Methods and compositions for prevention and treatment of diabetic and aged skin
CN102724994A (zh) 2010-01-11 2012-10-10 希尔洛有限公司 用于治疗炎性疾病和病症的方法
LT3302499T (lt) * 2015-06-05 2023-05-25 Fundació Hospital Universitari Vall D'hebron - Institut De Recerca Mitochondrinių ligų gydymas

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA835941A (en) * 1970-03-03 L. Ruskin Simon Synergistic effect of adenylic nucleotides in digitalis therapy
GB1336441A (en) * 1969-10-10 1973-11-07 Anvar Derivatives of cyclo adenosine-3,5-phosphoric acid and their preparation
JPS497414A (es) * 1972-05-24 1974-01-23
US3991045A (en) * 1973-05-30 1976-11-09 Asahi Kasei Kogyo Kabushiki Kaisha N4 -acylarabinonucleosides
FR2358155A1 (fr) * 1976-07-15 1978-02-10 Lapinet Eugene Composition pour le traitement et la prevention de l'irritation et de l'inflammation de la peau, de l'oeil et des muqueuses
FR2536278A1 (fr) * 1982-11-18 1984-05-25 Dupont Michele Nouvelle composition therapeutique utile notamment pour la cicatrisation des plaies
JPS59219235A (ja) * 1983-05-30 1984-12-10 Mitsui Toatsu Chem Inc 消化性潰瘍用剤
DE3481191D1 (de) * 1983-07-20 1990-03-08 Teijin Ltd Antineoplastisches mittel.
FR2556727B1 (fr) * 1983-12-19 1990-01-19 Biostabilex Labo Pharma Nouvelles compositions therapeutiques a base d'adn a haut poids moleculaire et leur procede de preparation
US4785553A (en) * 1987-07-07 1988-11-22 Miller Brewing Company Multilane oven

Also Published As

Publication number Publication date
RU2115410C1 (ru) 1998-07-20
FI905236A0 (fi) 1990-10-24
DK256290D0 (da) 1990-10-24
EP0420862A1 (en) 1991-04-10
ZA892928B (en) 1991-01-30
AU3571389A (en) 1989-11-24
WO1989010129A1 (en) 1989-11-02
DE68910973D1 (de) 1994-01-05
IN169469B (es) 1991-10-19
JPH03502694A (ja) 1991-06-20
DE68910973T2 (de) 1994-03-17
EP0420862A4 (en) 1991-02-18
DK176007B1 (da) 2005-11-21
CA1336264C (en) 1995-07-11
HK1005703A1 (en) 1999-01-22
JPH0635389B2 (ja) 1994-05-11
EP0420862B1 (en) 1993-11-24
AU621368B2 (en) 1992-03-12
DK256290A (da) 1990-12-21

Similar Documents

Publication Publication Date Title
MX9204268A (es) Una composicion para la liberacion prolongada y controlada de substancias medicamentosas y un proceso para preparar la misma.
NZ240230A (en) Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
ATE61050T1 (de) Pyridazinamine wirksam gegen viren.
IT1230742B (it) Composizione per aerosol comprendente nitroglicerina come ingrediente attivo.
AR027162A1 (es) Compuestos de 2-fenil-3-fenoxilo-feniltio-benzotiofeno, sales farmaceuticamente aceptables de los mismos y composiciones farmaceuticas que los contienen
DE3863963D1 (de) Pharmazeutische zusammensetzungen.
DE69403656D1 (de) Stabile, orale und absorbierbare therapeutische zusammensetzungen von nadh und nadph
IT8323205A0 (it) Composizioni farmaceutiche adattivita' antiinfiammatoria e/o analgesica, non ulcerogene.
ATE121295T1 (de) Augentropfenarzneimittel.
IT1231012B (it) Composizione farmaceutica per uso orale contenente nac.
IT8820386A0 (it) Composizioni farmaceutiche orosolubili contenti acetilcisteina.
MX171542B (es) Composiciones farmaceuticas que contienen deoxirribonucleosidos para cicatrizacion de heridas
BR9611642A (pt) Compostos composição farmacéutica e processo para a preparação de compostos
PT90743A (pt) Processo para a preparacao de derivados de hirudina com accao retardada e de composicoes farmaceuticas que os contem
IT8919074A0 (it) Composizione per l'igiene orale.
ES2177024T3 (es) Empleo de la fanquinoma para el tratamiento de la enfermedaad de alzheimer.
DE69521122D1 (de) 2,3,4,5-tetrahydro-1h-3-benzazepin säure-additions-salze
IT9047924A0 (it) Composizione per l'igiene orale.
ZA933455B (en) Thiochroman compounds, processes for the preparation thereof and pharmaceutical compositions containing them
DE69017969D1 (de) 2-Cyclohexylpropionsäure oder Derivate davon enthaltende Riechstoffzusammensetzung.
PT83472B (pt) Processo para a preparacao de composicoes anti-inflamatorias aperfeicoadas contendo piroxicamo
PT92345A (pt) Processo para a preparacao de composicoes farmaceuticas contendo derivados diterpenoides de labdano e derivados de pirimido(6,1-a)isoquinolina-4-ona
IL85517A (en) 3-(2-haloethyl)1,4-oxathiin and 2-(2-haloethyl)1,4-dithiin derivatives and pharmaceutical compositions containing the same
ES2065855B1 (es) Procedimiento para la preparacion de nuevos derivados desoxiazafosfolipidicos con accion inhibidora de la fosfolipasa a2, nuevos derivados desoxiazafosfolipidicos obtenidos y utilizacion de los mismos.
DE3866789D1 (de) Pharmazeutische zusammensetzungen.